| Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR. | |
| | |
MedLine Citation:
|
PMID: 14738437 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A new protocol for initiating warfarin therapy was introduced to reduce the workload in the Anticoagulant Clinic. A total of 200 outpatients, with a median age of 74 years, requiring anticoagulation for atrial fibrillation, commenced warfarin 3 mg daily for 1 week. Patients were initially seen weekly, and subsequent warfarin doses were dictated by the International Normalized Ratio (INR) on days 8 and 15; 84% of patients followed the protocol correctly: of these 86% had an INR > or =2 by day 15 and >98% had INR >2 by day 22. By day 22, 58% of patients achieved a stable dose, 85% by day 29 and >95% by day 36. Day 8 INR was predictive of the final maintenance dose required. No patient suffered any thrombotic or haemorrhagic complications in the first month: only three patients had an INR >3 on day 8, and 11 patients had an INR >4 on day 15. Patient age and sex were not sufficiently related to warfarin requirement to provide useful predictive information. This protocol, requiring only weekly INRs, has proved safe and effective for outpatient warfarinization, and has reduced clinic attendances in this population. |
| | |
Authors:
|
S Janes; R Challis; F Fisher |
Related Documents
:
|
23137667 - Predictive value of electrocorticography for postoperative epilepsy in patients with su... 17765427 - Safety of intravitreal injections in patients receiving warfarin anticoagulation. 1433657 - Current use of inferior vena cava filters. 23668867 - Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the fir... 19889067 - Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line trea... 8556187 - Recurrent thrombosis of omniscience prostheses in the mitral position: a case report. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical and laboratory haematology Volume: 26 ISSN: 0141-9854 ISO Abbreviation: Clin Lab Haematol Publication Date: 2004 Feb |
Date Detail:
|
Created Date: 2004-01-23 Completed Date: 2004-09-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7907061 Medline TA: Clin Lab Haematol Country: England |
Other Details:
|
Languages: eng Pagination: 43-7 Citation Subset: IM |
Affiliation:
|
Department of Haematology, St Richard's Hospital, Chichester, UK. sarah.janes@rws-tr.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Age Factors Aged Aged, 80 and over / physiology Anticoagulants / administration & dosage*, adverse effects Atrial Fibrillation / complications, drug therapy* Drug Administration Schedule Female Follow-Up Studies Hemorrhage / chemically induced Humans International Normalized Ratio / standards* Male Middle Aged Risk Factors Sex Factors Thrombosis / etiology, prevention & control* Time Factors Warfarin / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 81-81-2/Warfarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping scheme.
Next Document: Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ...